My injection record
Printed from glp1injectionsites.com
Where did you
inject today?
Keep your own record of the area and the day. It stays on this device.
Choose your medicine above. The body appears here, with the areas its label names shaded.
AbdomenThigh
Back of upper arm
- Chosen, not recorded yet
- Last recorded
- Earlier record
- Area the label names
“Inject MOUNJARO subcutaneously in the abdomen, thigh, or have another person inject MOUNJARO in the back of the upper arm.”
No area chosen
Choose an area on the body, or by name below.
Your record
Nothing recorded yet.
Kept in this browser, on this device. We never receive your entries. On iPhone, Safari can clear a site’s saved data after seven days of using Safari without visiting that site. Adding this site to your Home Screen avoids that.
Calendar reminder, and clear my record
Calendar reminder
A repeating event for your own calendar. It does not name your medicine.
Start over
Deletes your record and settings from this browser.
What the label says about rotating
“Rotate injection sites with each dose.”
“Change (rotate) your injection site each week. You may use the same area of your body but be sure to choose a different injection site in that area.”
“You or another person can inject the medicine in your thigh or stomach (abdomen) at least 2 inches from the belly button.”
What the Mounjaro label says for your device
The label’s own words on the dose schedule, a missed dose and time out of the fridge. Open any line’s source to see where it comes from.
“Single-dose pen or single-dose vial: 2.5 mg/0.5 mL, 5 mg/0.5 mL, 7.5 mg/0.5 mL, 10 mg/0.5 mL, 12.5 mg/0.5 mL, or 15 mg/0.5 mL”
- Prescribing information, for the Single-dose pen and Single-dose vial
- “DOSAGE FORMS AND STRENGTHS”
- Mounjaro (tirzepatide), revised 8/2026. How this label has changed
Dose schedule
“Use MOUNJARO 1 time each week, at any time of the day.”
- Medication Guide
- “How should I use MOUNJARO?”
- Mounjaro (tirzepatide), revised 8/2026. How this label has changed
“The recommended starting dosage of MOUNJARO is 2.5 mg injected subcutaneously once weekly”
- Prescribing information
- section 2.1
- Mounjaro (tirzepatide), revised 8/2026. How this label has changed
“If additional glycemic control is needed, increase the dosage in 2.5 mg increments after at least 4 weeks on the current dose.”
- Prescribing information
- section 2.1
- Mounjaro (tirzepatide), revised 8/2026. How this label has changed
“The maximum dosage of MOUNJARO is:”
- 15 mg injected subcutaneously once weekly in adults.
- 10 mg injected subcutaneously once weekly in pediatric patients.
- Prescribing information
- section 2.1
- Mounjaro (tirzepatide), revised 8/2026. How this label has changed
“You may change the day of the week you use MOUNJARO as long as the time between the 2 doses is at least 3 days (72 hours).”
- Medication Guide
- “How should I use MOUNJARO?”
- Mounjaro (tirzepatide), revised 8/2026. How this label has changed
Missed dose
“If you miss a dose of MOUNJARO, take the missed dose as soon as possible within 4 days (96 hours) after the missed dose. If more than 4 days have passed, skip the missed dose and take your next dose on the regularly scheduled day. Do not take 2 doses of MOUNJARO within 3 days of each other.”
- Medication Guide
- “How should I use MOUNJARO?”
- Mounjaro (tirzepatide), revised 8/2026. How this label has changed
The label also gives this limit in hours. Add the time to count hours.
Counts calendar days, or hours and minutes when a time is added, on this device. Nothing is saved or sent.
Out of the fridge
“Store each single-dose pen or single-dose vial in the refrigerator between 36⁰F to 46⁰F (2⁰C to 8⁰C). If needed, each single-dose pen or single-dose vial can be stored at room temperature up to 86⁰F (30⁰C) for up to a total of 21 days. Throw away single-dose pen or single-dose vial after a total of 21 days at room temperature.”
- Medication Guide, for the Single-dose pen and Single-dose vial
- “How should I store MOUNJARO?”
- Mounjaro (tirzepatide), revised 8/2026. How this label has changed
Mounjaro label revised 8/2026; every line checked against it 10 Nov 2026. How these lines have changed. Quoted word for word from the label as published on DailyMed, the National Library of Medicine’s label database. DailyMed’s current label may differ from the most recent label at Drugs@FDA.
What the labels say
The FDA labels for Mounjaro and Zepbound name the abdomen, the thigh and the upper arm, and say to change the injection site each week. Every line of both labels about where to inject is below, quoted word for word, with a tracker you can use for either.
Every quote is checked word for word against the label on DailyMed; last checked November 10, 2026.
The Mounjaro label
Mounjaro (tirzepatide), Eli Lilly. Label on DailyMed, revised 8/2026.
Every line of the Mounjaro label about injecting
Where to inject
“Inject MOUNJARO subcutaneously in the abdomen, thigh, or have another person inject MOUNJARO in the back of the upper arm.”
This label lists the sites above and does not say one is better or less painful than another.
The upper arm
“Another person should give you the injection in the back of your upper arm.”
The belly button
“You or another person can inject the medicine in your thigh or stomach (abdomen) at least 2 inches from the belly button.”
Changing the site
“Rotate injection sites with each dose.”
“Change (rotate) your injection site each week. You may use the same area of your body but be sure to choose a different injection site in that area.”
Skin to avoid
“Do not inject where the skin has pits, is thickened, or has lumps.”
With insulin
“It is acceptable to inject MOUNJARO and insulin in the same body region, but the injections should not be adjacent to each other.”
How often
“Administer MOUNJARO once weekly, any time of day, with or without meals.”
Supply
Not on FDA’s drug shortage list (checked November 10, 2026).
Source: FDA Drug Shortages database, via openFDA. Do not rely on openFDA to make decisions regarding medical care; check with your pharmacy.
Label history
15 label versions since January 2024; 8 changed the wording this site quotes, most recently August 27, 2026. See every change.
The Zepbound label
Zepbound (tirzepatide), Eli Lilly. Label on DailyMed, revised 8/2026.
Every line of the Zepbound label about injecting
Where to inject
“Inject ZEPBOUND subcutaneously in the abdomen, thigh, or another person should inject in the back of the upper arm.”
This label lists the sites above and does not say one is better or less painful than another.
The upper arm
“Another person should give you the injection in the back of your upper arm.”
The belly button
“You or another person can inject the medicine in your thigh or stomach (abdomen) at least 2 inches from the belly button.”
Changing the site
“Rotate injection sites with each dose.”
“Change (rotate) your injection site each week. You may use the same area of your body but be sure to choose a different injection site in that area.”
Skin to avoid
“Do not inject where the skin has pits, is thickened, or has lumps.”
With insulin
The label does not address this.
How often
“Administer ZEPBOUND once weekly at any time of day, with or without meals.”
Supply
Not on FDA’s drug shortage list (checked November 10, 2026).
Source: FDA Drug Shortages database, via openFDA. Do not rely on openFDA to make decisions regarding medical care; check with your pharmacy.
Label history
20 label versions since January 2024; 9 changed the wording this site quotes, most recently August 28, 2026. See every change.
Where the two labels differ
Both are tirzepatide from Eli Lilly, and their injection instructions are close to identical. Comparing which topics each label covers:
- With insulin: only the Mounjaro label addresses this; the Zepbound label does not.